Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell Therapy
Richard W. Joseph, Vijay R. Peddareddigari, Ping Liu, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 14, pp. 4882-4891
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Weiyi Peng, Jie Qing Chen, Chengwen Liu, et al.
Cancer Discovery (2015) Vol. 6, Iss. 2, pp. 202-216
Open Access | Times Cited: 1345
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano‐Goroff, Allison Betof Warner, Jedd D. Wolchok
Cell Research (2020) Vol. 30, Iss. 6, pp. 507-519
Open Access | Times Cited: 613
Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients
Laszlo Radvanyi, Chantale Bernatchez, Minying Zhang, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 24, pp. 6758-6770
Open Access | Times Cited: 390
Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma
Richard C. Wu, Marie-Andrée Forget, Jessica Chacon, et al.
The Cancer Journal (2012) Vol. 18, Iss. 2, pp. 160-175
Open Access | Times Cited: 217
Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
Abhisek Swaika, William A. Hammond, Richard W. Joseph
Molecular Immunology (2015) Vol. 67, Iss. 2, pp. 4-17
Closed Access | Times Cited: 192
Therapy for metastatic melanoma: the past, present, and future
Laura Finn, Svetomir N. Markovic, Richard W. Joseph
BMC Medicine (2012) Vol. 10, Iss. 1
Open Access | Times Cited: 211
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Eva Ellebæk, Trine Zeeberg Iversen, Niels Junker, et al.
Journal of Translational Medicine (2012) Vol. 10, Iss. 1
Open Access | Times Cited: 149
Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives
Jole Ventriglia, Immacolata Paciolla, Carmela Pisano, et al.
Cancer Treatment Reviews (2017) Vol. 59, pp. 109-116
Closed Access | Times Cited: 144
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12
Mireia Uribe‐Herranz, Kyle Bittinger, Stavros Rafail, et al.
JCI Insight (2018) Vol. 3, Iss. 4
Open Access | Times Cited: 136
Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapies
Anne Monette, Caroline Ceccaldi, Elias Assaad, et al.
Biomaterials (2015) Vol. 75, pp. 237-249
Open Access | Times Cited: 127
Adoptive Cell Transfer for Patients with Metastatic Melanoma: The Potential and Promise of Cancer Immunotherapy
Giao Q. Phan, Steven A. Rosenberg
Cancer Control (2013) Vol. 20, Iss. 4, pp. 289-297
Open Access | Times Cited: 109
Tumor-Infiltrating Lymphocytes in Melanoma
Sylvia Lee, Kim Margolin
Current Oncology Reports (2012) Vol. 14, Iss. 5, pp. 468-474
Open Access | Times Cited: 99
Characterization and Comparison of ‘Standard’ and ‘Young’ Tumour‐Infiltrating Lymphocytes for Adoptive Cell Therapy at a Danish Translational Research Institution
Marco Donia, Niels Junker, Eva Ellebæk, et al.
Scandinavian Journal of Immunology (2011) Vol. 75, Iss. 2, pp. 157-167
Closed Access | Times Cited: 94
Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response
Elizabeth A. Mittendorf, Gheath Alatrash, Na Qiao, et al.
Cancer Research (2012) Vol. 72, Iss. 13, pp. 3153-3162
Open Access | Times Cited: 83
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy
Ariel Isser, Natalie K. Livingston, Jonathan P. Schneck
Biomaterials (2020) Vol. 268, pp. 120584-120584
Open Access | Times Cited: 61
Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives
Ying Tang, Anne X.J. Zhang, Guangyu Chen, et al.
Molecular Therapy — Oncolytics (2021) Vol. 22, pp. 410-430
Open Access | Times Cited: 50
Immunotherapy of melanoma
John B.A.G. Haanen
European Journal of Cancer Supplements (2013) Vol. 11, Iss. 2, pp. 97-105
Open Access | Times Cited: 55
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?
Inge Marie Svane, Els M.E. Verdegaal
Cancer Immunology Immunotherapy (2014) Vol. 63, Iss. 10, pp. 1081-1091
Closed Access | Times Cited: 44
Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor)
Antoni X. Torres‐Collado, Jeffrey R. Knott, Ali R. Jazirehi
Cancers (2018) Vol. 10, Iss. 6, pp. 157-157
Open Access | Times Cited: 43
Adoptive Cell Therapy: Past, Present and Future
Jonathan Cohen, Sharon Merims, Stephen Jay Frank, et al.
Immunotherapy (2017) Vol. 9, Iss. 2, pp. 183-196
Closed Access | Times Cited: 40
Surgical Considerations in Tumor-Infiltrating Lymphocyte Therapy: Challenges and Opportunities
Amanda Kirane, David Lee, Charlotte E. Ariyan
Transplantation and Cellular Therapy (2025) Vol. 31, Iss. 3, pp. S591-S598
Open Access
Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion
Marco Donia, Morten Hansen, Sarah Louise Sendrup, et al.
Journal of Investigative Dermatology (2012) Vol. 133, Iss. 2, pp. 545-552
Open Access | Times Cited: 42
Current Adoptive Immunotherapy in Non-Small Cell Lung Cancer and Potential Influence of Therapy Outcome
Ya-Wen Zheng, Run-Mei Li, Xinwei Zhang, et al.
Cancer Investigation (2013) Vol. 31, Iss. 3, pp. 197-205
Closed Access | Times Cited: 37
Current Status of Biological Therapies for the Treatment of Metastatic Melanoma.
Tianyi Tang, Robert Eldabaje, Li‐Xi Yang
PubMed (2016) Vol. 36, Iss. 7, pp. 3229-41
Closed Access | Times Cited: 36
The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer
Guilherme Sacchi de Camargo Correia, Yujie Zhao, Rami Manochakian, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top